Fitzpatrick Mark J.
Insider CIK 1520265 · AEGR Chief Financial Officer · CHMA President and CEO, Director · ALNA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALNA Allena Pharmaceuticals, In | A Award deriv | 2021-04-06 | 2021-04-08 | 74,000 | — | $0 | 74,000 | SEC↗ |
| CHMA CHIASMA, INC | M Exercise deriv | 2020-12-04 | 2020-12-07 | 10,000 | — | $0 | 363,352 | SEC↗ |
| CHMA CHIASMA, INC | M Exercise | 2020-12-04 | 2020-12-07 | 10,000 | $2.60 | $26.0K | 19,612 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2020-02-14 | 2020-02-18 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2019-02-14 | 2019-02-15 | 186,000 | — | $0 | 186,000 | SEC↗ |
| CHMA CHIASMA, INC | P Buy | 2018-12-20 | 2018-12-21 | 9,612 | $2.50 | $24.0K | 9,612 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2018-02-23 | 2018-02-26 | 67,967 | — | $0 | 67,967 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2018-02-23 | 2018-02-26 | 194,183 | — | $0 | 194,183 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2016-10-25 | 2016-10-25 | 373,352 | — | $0 | 373,352 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2016-02-10 | 2016-02-12 | 70,000 | — | $0 | 70,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-04-01 | 2015-04-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-04-01 | 2015-04-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2014-12-31 | 2015-01-05 | 65,000 | — | $0 | 65,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2014-08-19 | 2014-08-20 | 1,150 | $30.64 | $35.2K | 9,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2014-04-01 | 2014-04-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2014-03-04 | 2014-03-05 | 2,500 | — | $0 | 189,650 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2014-03-04 | 2014-03-05 | 2,500 | $17.64 | $44.1K | 8,350 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2014-02-10 | 2014-02-12 | 7,500 | — | $0 | 192,150 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2014-02-10 | 2014-02-12 | 486 | $64.69 | $31.4K | 5,850 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2014-02-10 | 2014-02-12 | 3,300 | $61.71 | $203.6K | 10,050 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2014-02-10 | 2014-02-12 | 7,500 | $17.64 | $132.3K | 13,350 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2014-02-10 | 2014-02-12 | 900 | $63.72 | $57.3K | 6,336 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2014-02-10 | 2014-02-12 | 2,814 | $62.94 | $177.1K | 7,236 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-11-13 | 2013-11-13 | 2,850 | — | $0 | 199,650 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-11-11 | 2013-11-13 | 7,500 | — | $0 | 202,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-11-11 | 2013-11-13 | 622 | $78.38 | $48.8K | 9,278 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-11-11 | 2013-11-13 | 200 | $74.43 | $14.9K | 10,100 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-11-11 | 2013-11-13 | 200 | $73.01 | $14.6K | 10,300 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-11-11 | 2013-11-13 | 7,500 | $17.64 | $132.3K | 10,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-11-11 | 2013-11-13 | 4,478 | $79.34 | $355.3K | 4,800 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-11-11 | 2013-11-13 | 1,800 | $80.03 | $144.1K | 3,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-11-11 | 2013-11-13 | 2,850 | $17.64 | $50.3K | 5,850 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-11-11 | 2013-11-13 | 200 | $76.14 | $15.2K | 9,900 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-08-26 | 2013-08-28 | 2,500 | — | $0 | 210,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-08-26 | 2013-08-28 | 2,500 | $17.64 | $44.1K | 3,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-08-14 | 2013-08-16 | 7,500 | — | $0 | 212,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-08-14 | 2013-08-16 | 4,400 | $93.71 | $412.3K | 1,088 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-08-14 | 2013-08-16 | 588 | $94.44 | $55.5K | 500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-08-14 | 2013-08-16 | 7,500 | $17.64 | $132.3K | 8,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-08-14 | 2013-08-16 | 2,512 | $92.74 | $233.0K | 5,488 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2013-04-01 | 2013-04-03 | 27,500 | — | $0 | 27,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2012-03-23 | 2012-03-26 | 200 | $14.16 | $2.8K | 200 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2012-03-23 | 2012-03-26 | 300 | $14.15 | $4.2K | 500 | SEC↗ |